Treatment

Amna Anees

4 mins read - November 17, 2024

By suggesting pembrolizumab (Keytruda) in conjunction with chemotherapy as a first-line treatment for patients with malignant pleural mesothelioma, the European Medicines Agency’s ...

Amna Anees

2 mins read - September 23, 2024

The U.S. Food and Drug Administration (FDA) has approved the immunotherapy pembrolizumab (Keytruda) in combination with chemotherapy as an initial treatment for adults with metast...

Mary Pieper

5 mins read - August 15, 2024

What if a technology could look inside the human body not just to see what our organs looked like, but to track their processes as they function? For patients of the rare, aggress...

Mary Pieper

3 mins read - July 5, 2024

Frontiers in Oncology provisionally accepted a case report Friday suggesting the use of first-line nivolumab and ipilimumab could be more effective than chemotherapy in malignant ...

Mary Pieper

2 mins read - May 30, 2024

The FDA has granted Priority Review designation to Merck’s application for Keytruda (pembrolizumab) plus chemotherapy as a first-line treatment for patients with advanced or metast...

Jean Brannum

3 mins read - May 18, 2024

For patients diagnosed with the aggressive cancer mesothelioma, the choice of surgical treatment has always been a complex decision. Historically, the radical surgery to remove an...

Mary Pieper

2 mins read - May 14, 2024

A recent study led by researchers at Harvard Medical School suggests women with pleural mesothelioma (PM) who undergo a lung-sparing surgery called intended extended pleurectomy de...

Mary Pieper

4 mins read - May 2, 2024

In the ongoing battle against mesothelioma, the introduction of ADI-PEG20 (pegargiminase) marks a significant milestone. This innovative drug, hailed for its novel approach, targe...

Jean Brannum

2 mins read - December 24, 2023

Sellas Life Sciences, a prominent biopharmaceutical company in the U.S. focused on late-stage clinical developments, has recently announced encouraging results from its Phase I stu...

Amna Anees

2 mins read - October 9, 2023

A groundbreaking study led by researchers at The University of Texas at Austin introduces a novel drug that restores the effectiveness of immune cells in combating cancer. Pub...

Jean Brannum

2 mins read - February 14, 2022

A groundbreaking study led by researchers at Mayo Clinic Cancer Center in Florida is revolutionizing gastric cancer treatment by leveraging genomic sequencing to predict patient re...

Amna Anees

3 mins read - February 14, 2022

A recent study, led by researchers at Yale Cancer Center and the University of Maryland Comprehensive Cancer Center, has revealed promising results in the treatment of platinum/tax...

Jean Brannum

3 mins read - December 16, 2021

In a groundbreaking discovery, researchers at Wake Forest School of Medicine have unveiled a nanoparticle therapeutic that revolutionizes cancer immunotherapy, offering a promising...

Jean Brannum

3 mins read - November 8, 2021

Researchers at the forefront of cancer immunotherapy have unveiled a groundbreaking treatment avenue for patients battling inoperable pleural mesothelioma, a lethal lung cancer. ...

Amna Anees

2 mins read - October 10, 2021

In the realm of mesothelioma treatment, immunotherapy emerges as a beacon of hope, with researchers striving to unravel its potential against this rare and aggressive disease. ...

Jean Brannum

2 mins read - August 12, 2021

Bioengineers at the University of California San Diego have pioneered a groundbreaking cancer immunotherapy that harnesses ultrasound technology to target and destroy malignant tu...

Amna Anees

3 mins read - July 14, 2021

In a groundbreaking Phase II study, spearheaded by experts from The University of Texas MD Anderson Cancer Center, a formidable duo of drugs, atezolizumab, and bevacizumab, has em...

Cameron Ayers

2 mins read - April 23, 2021

Europe is poised to see a new first-line therapy for mesothelioma after getting the green light from a medical review agency.A division of the European Medicines Agency (EMA) — whi...

Patricia Shelton

2 mins read - April 14, 2021

An immunotherapy cocktail could aid relapsed mesothelioma patients without surgical options, according to a recent study.A team of Italian researchers reported that a combination o...

Cameron Ayers

3 mins read - April 6, 2021

A remarkable computer model focused on decoding the complex genetic interactions found in pleural mesothelioma cases could give researchers insight into future treatments for the d...

Cameron Ayers

3 mins read - March 24, 2021

An uncommon form of mesothelioma was the focus of two retrospective studies published this week: one focusing on untested treatments and the other on experimental gene research.The...